Howard Lin

568 total citations
8 papers, 68 citations indexed

About

Howard Lin is a scholar working on Physiology, Surgery and Genetics. According to data from OpenAlex, Howard Lin has authored 8 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 4 papers in Surgery and 4 papers in Genetics. Recurrent topics in Howard Lin's work include Histiocytic Disorders and Treatments (5 papers), Genetic and rare skin diseases. (4 papers) and Genital Health and Disease (2 papers). Howard Lin is often cited by papers focused on Histiocytic Disorders and Treatments (5 papers), Genetic and rare skin diseases. (4 papers) and Genital Health and Disease (2 papers). Howard Lin collaborates with scholars based in United States, Canada and Singapore. Howard Lin's co-authors include Sandra S. Salus, Karen S. Schumaker, Kenneth L. McClain, Olive S. Eckstein, Carl E. Allen, Daniel Zinn, Michael Poidinger, David Hostler, Zachary J. Schlader and Evan W. Newell and has published in prestigious journals such as Blood, British Journal of Haematology and Crop Science.

In The Last Decade

Howard Lin

6 papers receiving 56 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard Lin United States 4 32 24 18 12 9 8 68
A. P. Dodd United Kingdom 5 28 0.9× 23 1.0× 8 0.4× 10 0.8× 1 0.1× 8 143
Paolo D’Avino United States 5 6 0.2× 11 0.5× 18 1.0× 8 0.7× 4 0.4× 8 109
Christine M. Bradshaw United States 6 5 0.2× 15 0.6× 5 0.3× 27 2.3× 21 2.3× 10 74
Angela Yang United States 4 23 0.7× 36 1.5× 55 3.1× 4 0.3× 11 124
L. J. Masthoff Netherlands 7 6 0.2× 40 1.7× 37 2.1× 10 0.8× 8 325
Gloria Nguyen United States 4 6 0.2× 3 0.1× 6 0.3× 9 0.8× 3 0.3× 5 90
Xiangdong Guan China 4 3 0.1× 5 0.2× 10 0.6× 14 1.2× 7 0.8× 8 75
S. Kaul Germany 8 11 0.3× 100 4.2× 4 0.2× 6 0.5× 2 0.2× 13 240
J. Gayraud Spain 6 5 0.2× 60 2.5× 14 0.8× 4 0.3× 10 138
Qingqing Zhang China 5 7 0.2× 6 0.3× 5 0.3× 4 0.4× 11 54

Countries citing papers authored by Howard Lin

Since Specialization
Citations

This map shows the geographic impact of Howard Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Lin more than expected).

Fields of papers citing papers by Howard Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Lin. The network helps show where Howard Lin may publish in the future.

Co-authorship network of co-authors of Howard Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Lin. A scholar is included among the top collaborators of Howard Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Lin. Howard Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lin, Howard, Akanksha Batajoo, Harshal Abhyankar, et al.. (2024). Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis. British Journal of Haematology. 204(5). 1882–1887. 4 indexed citations
2.
Lin, Howard, Kenneth L. McClain, Nitya Gulati, et al.. (2023). Retrospective Analysis of Clofarabine Salvage Therapy in Refractory Multifocal Langerhans Cell Histiocytosis (LCH). Blood. 142(Supplement 1). 4574–4574. 1 indexed citations
3.
El‐Mallawany, Nader Kim, Howard Lin, Harshal Abhyankar, et al.. (2023). Responses to Combination Chemotherapy with MAPK Pathway Inhibition in Relapsed and Refractory LCH. Blood. 142(Supplement 1). 6349–6349.
4.
Peckham‐Gregory, Erin C., Priya B. Shetty, Howard Lin, et al.. (2023). Expanded Assessments of Germline Genetic Variants Identify Additional Risk Loci for Langerhans Cell Histiocytosis. Blood. 142(Supplement 1). 3193–3193. 1 indexed citations
6.
Johnson, Blair D., et al.. (2020). Inferior Vena Cava Diameter is an Early Marker of Central Hypovolemia during Simulated Blood Loss. Prehospital Emergency Care. 25(3). 341–346. 6 indexed citations
7.
Lim, Karen Phaik Har, Paul Milne, Michael Poidinger, et al.. (2020). Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells. Blood Advances. 4(1). 87–99. 23 indexed citations
8.
Lin, Howard, Sandra S. Salus, & Karen S. Schumaker. (1997). Salt Sensitivity and the Activities of the H+‐ATPases in Cotton Seedlings. Crop Science. 37(1). 190–197. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026